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Abstract
Objective: The clavulanic acid regulatory gene (claR) is in the clavulanic acid biosynthetic 
gene cluster that encodes ClaR. This protein is a putative regulator of the late steps of 
clavulanic acid biosynthesis. The aim of this research is the molecular cloning of claR, 
isolated from the Iranian strain of Streptomyces clavuligerus (S. clavuligerus). 
Materials and Methods: In this experimental study, two different strains of S. clavuligerus 
were used (PTCC 1705 and DSM 738), of which there is no claR sequence record for 
strain PTCC 1705 in all three main gene banks. The specific designed primers were sub-
jected to a few base modifications for introduction of the recognition sites of BamHI and 
ClaI. The claR gene was amplified by polymerase chain reaction (PCR) using DNA iso-
lated from S. clavuligerus PTCC 1705. Nested-PCR, restriction fragment length polymor-
phism (PCR-RFLP), and sequencing were used for molecular analysis of the claR gene. 
The confirmed claR was subjected to double digestion with BamHI and ClaI. The cut claR 
was ligated into a pBluescript (pBs) vector and transformed into E. coli.
Results: The entire sequence of the isolated claR (Iranian strain) was identified. The 
presence of the recombinant vector in the transformed colonies was confirmed by the 
colony-PCR procedure. The correct structure of the recombinant vector, isolated from the 
transformed E. coli, was confirmed using gel electrophoresis, PCR, and double digestion 
with restriction enzymes. 
Conclusion: The constructed recombinant cassette, named pZSclaR, can be regarded 
as an appropriate tool for site directed mutagenesis and sub-cloning. At this time, claR 
has been cloned accompanied with its precisely selected promoter so it could be used in 
expression vectors. Hence the ClaR is known as a putative regulatory protein. The over-
produced protein could also be used for other related investigations, such as a mobility 
shift assay. 
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Introduction
Streptomyces species are mycelial, aerobic gram-
positive bacteria readily isolated from soil (1, 2). 
Streptomyces are unique among prokaryotes due 
to their complicated morphological differentiation 
(3). These morphological changes are accompanied 
by a wide range of physiological events, including 
the production of secondary metabolites, many of 
which have potentially important biological activi-
ties. They include many useful antibiotics and oth-
er products, such as antitumor drugs and herbicides 
(4-8). Streptomyces clavuligerus (S. clavuligerus) 
produces the β-lactam antibiotic, cephamycin 
C and the β-lactamase inhibitor, clavulanic acid 
(9-11). Clavulanic acid is a clinically significant 
inhibitor of β-lactamases, while the other clavam 
metabolites produced by S. clavuligerus demon-
strate weak antibacterial and antifungal activities 
(1, 9). Several other Streptomyces species have 
also been determined to be producers of clavulanic 
acid (12, 13). The combined use of clavulanic acid 
and broad-spectrum β-lactam antibiotics such as 
amoxicillin are an important therapeutic tactic to 
combat the rapid increase in β-lactam resistance 
(14-17). The cluster of genes for clavulanic acid 
biosynthesis is located downstream from the pcbC 
gene of the cephamycin C cluster in S. clavuligerus 
(18, 19). Most genes of the cephamycin and clavu-
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lanic acid clusters are known (20-24). All essential 
genes of the clavulanic acid pathway are within a 
12kb EcoRI DNA fragment of the S. clavuligerus 
genome, because this fragment appears to confer 
production of clavulanic acid when introduced in 
Streptomyces lividans (25). Very little is known 
about the regulation of the genes of the clavulanic 
acid cluster. The transcriptional activators CcaR 
and ClaR are known to regulate the expression of 
clavulanic acid biosynthetic genes (26-28). The 
ccaR gene lies within the cephamycin biosynthetic 
gene cluster. This gene is a pathway-specific tran-
scriptional regulator for cephamycin biosynthesis, 
as well as a controlling expression of the claR gene 
from the clavulanic acid gene cluster (21, 29-31). 
Another regulatory gene, claR, is located immedi-
ately downstream from orf-7 in the clavulanic acid 
cluster and encodes a 431 amino acid protein (31, 
32). The regulatory nature of the ClaR protein has 
been deduced from the presence of one helix turn 
helix (HTH) motif and flanking sequences which 
show significant similarity to LysR transcriptional 
regulators (33). Finally, the absence of orf-7, orf-9 
and orf-10 transcripts in a claR mutant blocked in 
clavulanic acid production confirmed the regula-
tory role of ClaR (32- 34). 
To increase the amount of clavulanic acid produced 
by S. clavuligerus, different tactics have been em-
ployed by researchers. Enhancement of clavulanic 
acid production was seen in S. clavuligerus in the 
presence of peanut (Arachis hypogaea) seed flour 
and its fractions (35). Random mutagenesis was 
performed on S. clavuligerus. The new mutated 
strains were able to produce the elevated level of 
clavulanic acid (36). 
Since clavulanic acid is produced industrially by 
fermentation using S. clavuligerus, the regulation 
of clavulanic acid biosynthesis is a point of great 
interest. It has been shown that the cloning of the 
claR gene in the S. clavuligerus resulted in a three-
fold increase in clavulanic acid production (31). In 
our previous work, an isolated claR gene was ligat-
ed to a Streptomyces specific vector (pMA::hyg). 
The cloned claR genes had been isolated from two 
standard strains of Streptomyces. 
In this work, a new recombinant construct that 
carries the claR regulatory gene is presented. This 
vector not only transfers the claR gene isolated 
from one Iranian strain of S. clavuligerus, but also 
contains an inducible promoter. 
Materials and Methods
Bacterial strains 
S. clavuligerus DSM 41826 (DSM, Germany) and 
S. clavuligerus PTCC 1705 (Iranian Scientific and 
Industrial Research Organization, Iran) were used 
in this study. Escherichia coli (E. coli) XL1-Blue 
was also used in this study. The Streptomyces 
strains were grown in defined conditions as de-
scribed previously (37). A suspension of Strepto-
myces spores was prepared in 20% (v/v) glycerol 
and stored at -20°C (38). Cultures for the isolation 
of chromosomal DNA were prepared by inoculat-
ing 100 ml of yeast extract medium (YEM) with 
100 μl of spore suspension. The YEM medium 
was prepared as described previously (37). Luria-
bertani (LB) agar medium (that contained per liter: 
10 g of trypton, 5 g of bacto-yeast extract, 10 g 
of NaCl and 17 g of agar; pH= 7.5) supplemented 
with Ampicillin (100 μg/ml), whenever required, 
was used for the propagation of E. coli at 37°C. 
The bacterial pellet was stored in 20% glycerol at 
-20°C. 
Vector 
The pBs SK reproduced from Stratagene Cata-
logue was used as the vector in this study.
Primers 
OLIGO® version 5.0 software (39) was used for 
designing all primers. The entire coding region 
of the gene was considered for primer selection. 
Accession number AJ000671.1, GI:2764535 (or 
U87786.2, GI:9280818) was used for obtaining 
the claR sequence. These accession numbers are 
based on S. clavuligerus ATCC 2706. This strain 
is the same as S. clavuligerus DSM 738, as men-
tioned in the NCBI. One set of primers (claR1) 
was designed for nested PCR (F: 5′GCC TGG 
AGC AGA TGG AG 3′and R: 5′AGG TGC TGT 
CGC TGG TCT 3′). Two primers (claR2) were de-
signed for isolation of the claR gene from genomic 
DNA of S. clavuligerus (F: 5′CAT GGA TCC GTA 
TCT GTA CC 3′ and R: 5′TAG GAT CGA TTC 
CGA AGC 3′). These primers were subjected to 
modification at each 5' end in order to have two 
recognition sites for BamHI and ClaI (Fig 1). 
Separation of total genomic DNA from Strepto-
myces 
Total genomic DNA was isolated from the liquid 
culture of Streptomyces using the High Pure PCR 
Template Preparation Kit (Roche; Cat. No.1 796 
828). The amount of DNA was quantified by gel 
electrophoresis and spectrophotometric analysis.
Polymerase chain reaction (PCR )
The reaction mixture for PCR amplification 
was prepared as follows: forward primer, 20 
pM; reverse primer, 20 pM; dimethyl sulfoxide 
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(DMSO), 4 μl; 10×PCR buffer without MgSO4 
(200 mM Tris-HCl, 100 mM (NH4)2SO4, 100 mM 
KCl, 1% (v/v) Triton X-100, 1 mg/ml bovine se-
rum albumin (BSA)), 5 μl; MgSO4, 3 μl; deoxy-
nucleoside triphosphates (dNTPs), 2 μl (10 mM 
each dNTP); and H2O, up to 50 μl. A total of 100 
ng of chromosomal DNA was added as the tem-
plate DNA. The PCR reactions were then carried 
out using 0.3 μl (2.5 U/μl) of Pfu polymerase en-
zyme. The amplification steps for the main PCR 
were as follows: hot start at 95°C for 5 minutes; 
33 cycles of denaturation at 94°C for 1 minute, 
annealing at 60°C for 1 minute, primer extension 
at 72°C for 4 minutes, and a final extension at 
72°C for 15 minutes. These conditions were set 
up for the modified primers. The amplification 
procedure was slightly different for the nested 
primers. The PCR was carried out normally for 
30-35 cycles. The products were visualized by a 
standard electrophoresis procedure using 0.7% 
(W/V) agarose gels.
Restriction endonuclease (RE) digestion 
Two sets of primers were designed not only to ampli-
fy the claR region, but also to integrate one unique 
recognition site (BamHI and ClaI) in each end of 
the amplified fragments. Digestion was performed 
following the recommendations of the manufac-
turer (Fermentas, Germany). Required amounts of 
DNA samples (0.2-5 μg) were generally digested 
with 5-10 units of restriction enzymes (BamHI and 
ClaI) in a 10-20 μl final volume of restriction buffer 
(10× buffer) for about 1-3 hours in a water bath at 
the recommended temperature (normally 37°C). A 
sample was run on an agarose gel after incubation 
with each enzyme, which ensured that the digestion 
was done completely (40).
DNA ligation 
DNA ligation was performed using one unit of T4 
DNA ligase (Fermentas, Germany) in the presence 
of 1× ligation buffer. The 3:1 molar ratio of insert 
to vector was used in order to optimize transfor-
mation. Incubation was done at 16°C overnight 
(40). The products of the ligase reaction (a 20 ng 
aliquot from the completed ligase mixture) were 
analyzed by electrophoresis on a 2 × 50 ×75 mm 
agarose gel (mini gel).
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ClaR2(F)primer with BamHlRS
claR(PCR product: 1669bp)
*  G  S  M  R  A  G  ...
11039
. . . . . . .
10835   5   catcgttccgtatctgtacccgcgg / / gacccggtcgcggcccgctcaagccggacatccgggccc //
3   gtagcaaggcatagecatgggcgcc / / ctgggccagcgccgggcgAGTtcggcctgcaggcccgg // 
CATGGATCCGTATCTGTACC
TTCGGA ATCGATCCTA
ClaR2(R)primerwithClalR.S
R   A   V   E   M
12337
. . .
ccgggccacttccatgaggtctccgcag / / agtggctcttgaattgcttcggaatcgatccta  3  12503
ggcccggtgaagGTActccagaggcgtc / / tcaccgagaacttaacgaagccttagctaggat   5
Fig 1: Nucleotide sequence of the claR gene. The main primers have been subjected to a few nucleotide modifications as 
shown here (This figure has also been printed in full-color at the end of this issue).
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Fig 2: Amplification of claR  with its native promoter-
from S. clavuligerus PTCC 1705 by PCR.
I. S. clavuligerus total genomic DNA (isolated ei-
ther from DSM738 or PTCC 1705) was used in the 
PCR reaction. The numbers are in base pair (bp), II. 
PTCC1705, III. DSM738, M.   Marker; GeneRulerTM 
1kb DNA ladder.
On the other hand, the results of the nested PCR have 
confirmed the approximate similarity between these 
two genes (claR isolated from Iranian S. clavuligerus 
and S. clavuligerus DSM738). This conclusion 
was achieved because the claR sequence of S. cla-
vuligerus DSM738 had been used to design the prim-
ers. RFLP- PCR was then carried out using the SalI 
restriction enzyme. SalI cuts the claR gene at 740 and 
1331 bp, producing three fragments, 740, 591 and 
338 bp. The resultant fragments confirmed the cor-
rect structure for the isolated claR gene (Fig 3). 
Fig 3: Molecular study of the claR, using restriction diges-
tion analysis. PCR amplified claR was cut with different 
restriction enzymes. The results are visualized by gel elec-
trophoresis (2%). The numbers are in bp.
I. Cut with XbaI: This enzyme does not cut the claR fragment, 
II. Cut with SalI: This enzyme cuts the claR at two sites 740 
and 1331 (leaving three fragments, 740 bp, 591 bp and 338 bp), 
M. Marker; GeneRulerTM 100 bp DNA Ladder Plus. 
Transformation of E. coli 
For making competent cells from E. coli, the cal-
cium chloride method was used (40). An aliquot 
(200 μl) of frozen competent cells were slowly 
thawed on ice for about 30 minutes. Cells were 
gently mixed with DNA and incubated on ice for 
30 minutes. The cells were then heat shocked at 
42°C for 90 seconds. They were added to 2 ml LB 
(without antibiotic) and incubated at 37°C for one 
hour in a shaking incubator. A total of 100 μl of 
transformed cells were spread on the surface of the 
LB plate that contained an antibiotic. The plates 
were allowed to dry before overnight incubation 
at 37°C (40). 
Extraction of plasmid DNA from E. coli 
E. coli DNA was isolated according to the method 
described by Holmes and Quigley (40). The over-
night LB culture of E. coli was harvested by cen-
trifugation (13K rpm, 30 seconds). The pellet was 
re-suspended in 350 μl of STET [0.3 M NaCl, 10 
mM Tris-HCl (pH= 8.0), 1mM EDTA (pH= 8.0), 
0.5% Triton X-100] buffer, and subsequently 25 μl 
of freshly prepared lysozyme solution (10 mg/ml 
lysozyme in 10 mM TrisCl) was added. The tube 
that contained bacterial lysate was placed in a boil-
ing water bath for 40 seconds before centrifugation 
at room temperature (12K rpm, 10 minutes). The 
pellet of bacterial cell debris was removed using 
a sterile toothpick. Plasmid DNA was precipitated 
with cold sodium acetate and isopropanol, washed 
with 70% ethanol, and re-dissolved in 50 μl of TE 
containing 10 g/ml RNase (40).
DNA sequencing 
DNA sequencing was carried out using the Applied 
Biosystem (ABI) system (Bioneer, Italy).
Results
Isolation and molecular analysis of claR gene 
Total DNA was isolated from Streptomyces and 
subjected to gel electrophoresis to analyze the con-
centration and purity. The pure, isolated total DNA 
was used for PCR reactions. Two different sets of 
primers were used. The claR gene was successfully 
amplified by using the claR2 primer set (Fig 2). 
The isolated fragment had to be studied in more 
detail to further compare it with the original claR 
of S. clavuligerus DSM738. Two different strate-
gies were conducted to not only confirm the ampli-
fied fragment as claR gene, but to also compare it 
with the claR gene sequence from S. clavuligerus 
DSM738. Initially nested PCR, using the claR1 
primer set, confirmed the existence of claR gene 
(data not shown). 
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Sequencing analysis of the claR gene revealed 
that the claR gene was amplified and sub-cloned, 
free from any mutation that was also essential for 
the correct expression of the gene. Bioinformat-
ics analysis determined the complete similarity 
between the isolated claR of the Iranian strain S. 
clavuligerus and S. clavuligerus 738 (Fig 4). 
Fig 4: Structural analysis of the cloned claR, isolated from 
S. clavuligerus PTCC 1705. The start codon (ATG) of the 
claR gene has been shown here along with a few initial se-
quences related to amino acids E, V, A, and R. Not all the se-
quences have been shown (This figure has also been printed 
in full-color at the end of this issue).
The sequence of the claR gene from S. clavuligerus 
PTCC 1705 was determined for the first time in this 
study and will be submitted to the DDBJ/EMBL/
GenBank databases in the near future. 
Cloning of the claR gene 
E. coli XL1-Blue was transformed with pBS plas-
mid. The pBs plasmid was then isolated from the 
transformed E. coli and subjected to double diges-
tion (with BamHI and ClaI), gel electrophoresis, 
and gel purification. The PCR amplified fragment 
was also double digested with BamHI and ClaI, 
and the resultant cut fragment was purified by gel 
electrophoresis. A ligation mixture was set up us-
ing the double digested vector and the claR gene. 
E. coli XL1-Blue competent cells were trans-
formed using 10 μl of the ligation mixture. About 
20 colonies were observed on each plate, which 
was inoculated with 100 μl of the transformed 
cells of E. coli XL1-Blue. 
Therefore, the recombinant plasmid was isolated 
from a transformed colony. Molecular studies 
were then conducted on a 4581 bp new construct 
named pZSclaR (Fig 5). The isolated plasmid 
was subjected to gel electrophoresis for initial 
confirmation of the size of the constructed vec-
tor (Fig 6). 
pZSclaR was then cut with BamHI and ClaI for 
further confirmation of its structure and the result-
ant fragments were separated and visualized by gel 
electrophoresis. 
 
pZSclaR
4581 bps
SacI
SacII
BstXI
EagI
NotI
XbaI
SpeI
BamHI
ClaI
SalI
AccI
HincII
XhoI
ApaI
DraII
KpnI
AflIII
PvuI
ScaI
SspI
MCS
claR
colE ori
amp
f1+
f1-
lacZ
T7 promoter
T3 promoter
Fig. 5: A physical map of the vector pZSclaR, 4581 bp. This 
plasmid map was drawn using computer software Clone 
Manager 6 (This figure has also been printed in full-color 
at the end of this issue).
Fig. 6:  Structural confirmation of the pZSclaR using re-
striction digestion analysis. The pZSclaR plasmid was sub-
jected to double digestion with BamHI and ClaI.  The cut 
fragments were subjected to gel electrophoresis (0.7 %). 
Numbers are in bp.
I. pZSclaR plasmid (uncut: 4581 bp), II. pZSclaR plasmid 
cut with BamHI and ClaI, M. Marker Gene Ruler™ 1kb 
DNA Ladder.  
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These two enzymes cut the pZSclaR plasmid 
(4581) and separated the claR gene (1650 bp) from 
the original vector (pBs; 2931 bp). pZSclaR was 
then used as the PCR template in a PCR reaction 
containing nested primers that could confirm the 
existence of the claR gene. Therefore the correct 
recombinant plasmid did exist in the recombinant 
strain of E. coli. 
Discussion
The overall aim of this work was to expand our 
knowledge of the regulation of antibiotic produc-
tion in Streptomyces (the producer of two thirds of 
all known microbial antibiotics). Genetic engineer-
ing of the clavulanic acid producing strains could 
be done afterwards, in order to increase the capac-
ity of clavulanic acid production in S. clavuligerus. 
It has been reported that cdaR, the regulatory gene 
for the production of a calcium dependent antibi-
otic (CDA), positively regulates its own transcrip-
tion. As a result, introducing extra copies of cdaR 
into different strains of Streptomyces coelicolor 
MT1110, S. coelicolor 2377 and Streptomyces 
lividans has led to overproduction of this antibi-
otic (41). Designing novel antibiotics, on the other 
hand, is greatly dependent on the structural analy-
sis of the gene cluster for each antibiotic. Clavu-
lanic acid is a multi-billion-dollar per annum prod-
uct useful for its β-lactamase inhibitory activity. 
While the biosynthesis of clavulanic acid has been 
the subject of intense investigation in recent years, 
the details of its production and regulation are still 
not completely worked out. 
Amplification of the ccaR gene, a regulatory gene 
in the cephamycin gene cluster, resulted in an al-
most threefold increase in the production of both 
cephamycin and clavulanic acid in S. clavuligerus 
(20). The formation of clavulanic acid is controlled 
by a LysR-type regulatory protein encoded by the 
claR gene. The claR gene was then chosen because 
this is a putative regulatory gene in the production 
pathway of clavulanic acid (33). The claR gene, 
which is located downstream from the gene encod-
ing clavaminate synthase in the clavulanic acid 
biosynthesis gene cluster, is involved in regula-
tion of the late steps in clavulanic acid biosynthe-
sis (32-34). Amplification of the claR gene using 
multi-copy plasmids and under its own promoter 
in S. clavuligerus results in a three-fold increase in 
clavulanic acid production (31). 
We precisely amplified the coding sequence of claR 
accompanied with its promoter by using a specifi-
cally designed primer and an error proof PCR. In 
this case, only the promoter sequence of the gene 
comes with the claR. Since the distance between 
the vector born promoter and the claR transcrip-
tion start point is not too great, the expression of 
the cloned gene could also be started by two indi-
vidual promoters that exist in the vector. There-
fore, the usage of three promoters (one native claR 
gene and two vector-born) leads to an elevated 
level of claR gene expression. Prior to this study 
and in contrast to other regulatory genes in S. cla-
vuligerus, claR has not been isolated by PCR, but 
has been previously cloned via restriction enzyme 
digestion (31). For the first time, in the present 
study, the claR gene was isolated from an Iranian 
strain of S. clavuligerus PTCC 1705. The PCR iso-
lated claR was initially compared with the claR se-
quence of S. clavuligerus DSM 738, using nested 
PCR and restriction digestion analysis. The claR 
isolated from the S. clavuligerus PTCC 1705 was 
finally sequenced. Thus the entire sequence of S. 
clavuligerus claR was determined. The sequenc-
ing data was subjected to bioinformatics analysis 
for further comparison with the claR sequence of 
S. clavuligerus 738 and other species. Complete 
similarity was found between the sequence of 
claR isolated from PTCC 1705 and S. clavuligerus 
DSM 738.
In our previous work, claR was ligated into a Strep-
tomyces specific vector, pMA::hyg (39). However 
that vector does not have any inducible promoter. 
On the other hand, pMA::hyg does not contain any 
other cut sites for other restriction enzymes (39), 
so the subcloning of claR was practically impos-
sible. To overcome these problems, new primers 
were designed with new incorporated cut sites for 
BamHI and ClaI. The amplified claR was then 
cloned in E.coli by using a newly constructed 
vector called pZSclaR (Fig 4). This unique vec-
tor contains a greatly expanded multiple cloning 
site (MCS), which makes it suitable for different 
purposes of gene cloning. Furthermore, this new 
construct is expression and inducible. In the same 
way, increasing the copy number of certain clavu-
lanic acid-specific biosynthetic genes, by the in-
troduction of multiple copy expression plasmids, 
resulted in positive effects on the production of 
clavulanic acid (42). 
Conclusion 
Characterization of isolated claR from an Iranian 
strain of S. clavuligerus PTCC 1705 was carried 
out using molecular studies. This gene was cloned 
in E. coli via a multiple copy expression vector. 
The constructed recombinant cassette (pZSclaR) 
may also be utilized as an appropriate tool for site 
directed mutagenesis and sub-cloning. The ClaR 
is recognized as a putative regulatory protein, so 
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the overproduced protein could also be used for 
other related investigations, such as an enzyme as-
say and a mobility shift assay. The claR gene could 
also be expressed in Streptomyces by sub-cloning 
it into different varieties of Streptomyces specific 
expression vectors.
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